Terms: = Head and neck cancer AND PSA AND Treatment
40 results:
1. A Pilot Study on Patient-specific Computational Forecasting of Prostate cancer Growth during Active Surveillance Using an Imaging-informed Biomechanistic Model.
Lorenzo G; Heiselman JS; Liss MA; Miga MI; Gomez H; Yankeelov TE; Reali A; Hughes TJR
Cancer Res Commun; 2024 Mar; 4(3):617-633. PubMed ID: 38426815
[TBL] [Abstract] [Full Text] [Related]
2. Tislelizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy as First-Line treatment for Chinese Patients with Advanced Esophageal Squamous Cell Carcinoma: A Cost-Effectiveness Analysis.
Lu S; Lou Y; Rong Y; Huang Z; Lin X; Chen J; Luo K
Clin Drug Investig; 2023 Aug; 43(8):643-652. PubMed ID: 37542611
[TBL] [Abstract] [Full Text] [Related]
3. Management of Localized Prostate cancer in Men With Human Immunodeficiency Virus: Analysis of a Large Retrospective Cohort.
Vaziri T; Rao YJ; Whalen M; Bethony J; Thakkar P; Lin J; Goyal S
Clin Genitourin Cancer; 2023 Oct; 21(5):614.e1-614.e8. PubMed ID: 37208248
[TBL] [Abstract] [Full Text] [Related]
4. Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate cancer After Failure of Lutetium-177-PSMA.
Feuerecker B; Tauber R; Knorr K; Heck M; Beheshti A; Seidl C; Bruchertseifer F; Pickhard A; Gafita A; Kratochwil C; Retz M; Gschwend JE; Weber WA; D'Alessandria C; Morgenstern A; Eiber M
Eur Urol; 2021 Mar; 79(3):343-350. PubMed ID: 33293081
[TBL] [Abstract] [Full Text] [Related]
5. Cost-effectiveness analysis of nivolumab in the second-line treatment for advanced esophageal squamous cell carcinoma.
Zhang PF; Xie D; Li Q
Future Oncol; 2020 Jun; 16(17):1189-1198. PubMed ID: 32407173
[No Abstract] [Full Text] [Related]
6. Cost-effectiveness of chemoradiation followed by esophagectomy versus chemoradiation alone in squamous cell carcinoma of the esophagus.
Salcedo J; Suen SC; Bian SX
Cancer Med; 2020 Jan; 9(2):440-446. PubMed ID: 31749330
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical characteristics of patients with cervical vascular pseudoaneurysm after radiotherapy for nasopharyngeal carcinoma].
Song Y; Fu MY; Chen Y; Chen GP; Pan Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Aug; 33(8):746-748. PubMed ID: 31446731
[No Abstract] [Full Text] [Related]
8. A novel case of NKX3.1-positive metastatic cutaneous prostate cancer.
Wong JK; Minni JP; Nowak MA
Dermatol Online J; 2018 Oct; 24(10):. PubMed ID: 30677815
[TBL] [Abstract] [Full Text] [Related]
9. Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
Jereczek-Fossa BA; Maucieri A; Marvaso G; Gandini S; Fodor C; Zerini D; Riva G; Alessandro O; Surgo A; Volpe S; Fanetti G; Arculeo S; Zerella MA; Parisi S; Maisonneuve P; Vavassori A; Cattani F; Cambria R; Garibaldi C; Starzyńska A; Musi G; De Cobelli O; Ferro M; Nolè F; Ciardo D; Orecchia R
Med Oncol; 2018 Nov; 36(1):9. PubMed ID: 30483899
[TBL] [Abstract] [Full Text] [Related]
10. Synchronous Laryngeal Squamous Cell Carcinoma and Intrahepatic Cholangiocarcinoma Present in an Obese Male with Poor Prognosis.
Jiang P; Gu L; Zhou Y; Zhao Y; Lai J
Anticancer Res; 2018 Sep; 38(9):5547-5550. PubMed ID: 30194215
[TBL] [Abstract] [Full Text] [Related]
11. Platinum-based concurrent chemotherapy remains the optimal regimen for nasopharyngeal carcinoma: a large institutional-based cohort study from an endemic area.
Yu Y; Liang H; Lv X; Ke L; Qiu W; Huang X; Liu G; Li W; Guo X; Xiang Y; Xia W
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2231-2243. PubMed ID: 30109501
[TBL] [Abstract] [Full Text] [Related]
12. Metastasising Pleomorphic Salivary Adenoma: A Rare Case Report of a Massive Untreated Minor Salivary Gland Pleomorphic Adenoma with Concurrent Ipsilateral Cervical Node Metastases.
Watson M; McAllister P; Conn B; MacNeill M; Handley TPB
Head Neck Pathol; 2019 Sep; 13(3):500-506. PubMed ID: 29725854
[TBL] [Abstract] [Full Text] [Related]
13.
Maurer T; Robu S; Schottelius M; Schwamborn K; Rauscher I; van den Berg NS; van Leeuwen FWB; Haller B; Horn T; Heck MM; Gschwend JE; Schwaiger M; Wester HJ; Eiber M
Eur Urol; 2019 Apr; 75(4):659-666. PubMed ID: 29625755
[TBL] [Abstract] [Full Text] [Related]
14. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract] [Full Text] [Related]
15. Cost-effectiveness of nivolumab for recurrent or metastatic head and neck cancer☆.
Ward MC; Shah C; Adelstein DJ; Geiger JL; Miller JA; Koyfman SA; Singer ME
Oral Oncol; 2017 Nov; 74():49-55. PubMed ID: 29103751
[TBL] [Abstract] [Full Text] [Related]
16. [MOLECULAR MARKERS FOR PROSTATE cancer].
Engelstein D
Harefuah; 2017 May; 156(5):318-321. PubMed ID: 28551905
[TBL] [Abstract] [Full Text] [Related]
17. Dosimetry study on radioactive particle brachytherapy in oral carcinoma.
Jie Z; Jian M; Qianwei Z; Zhiping L
J BUON; 2017; 22(2):519-523. PubMed ID: 28534379
[TBL] [Abstract] [Full Text] [Related]
18. Glomus tumor of the trachea: a rare case report.
Wang H; Xie J; Tan Y; Jiang J
Int J Clin Exp Pathol; 2015; 8(8):9723-6. PubMed ID: 26464745
[TBL] [Abstract] [Full Text] [Related]
19. Advanced carcinoma of the prostate presenting as a supraclavicular mass: case report.
Agbugui JO; Obarisiagbon EO; Ugiagbe EE
Niger Postgrad Med J; 2014 Sep; 21(3):269-71. PubMed ID: 25331247
[TBL] [Abstract] [Full Text] [Related]
20. Pleomorphic adenomas: post-operative radiotherapy is unnecessary following primary incomplete excision: a retrospective review.
Robertson BF; Robertson GA; Shoaib T; Soutar DS; Morley S; Robertson AG
J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):e297-302. PubMed ID: 25287582
[TBL] [Abstract] [Full Text] [Related]
[Next]
